Normandy Hadrontherapy

Normandy Hadrontherapy (NHa) is a medtech company engineering a cyclotron-based particle therapy system, the C400 IONS, being more compact, more affordable, and easier to use and maintain than existing systems. The superconducting cyclotron is the heart of the world's first compact multi-ions therapy system (carbon, heliums proton and others). This innovative solution will offer advanced heavy-ion therapy with benefits for many cancer indications, especially for large, hypoxic and radio resistant tumors.

• Employees 40
• Founded 2019